Research Paper Volume 14, Issue 23 pp 9699—9714
Establishing a signature based on immunogenic cell death-related gene pairs to predict immunotherapy and survival outcomes of patients with hepatocellular carcinoma
Figure 6. Chemotherapy sensitivity and functional enrichment analyses. (A–F) Boxplots of the IC50 values of the Temsirolimus, Bortezomib, Metformin, Paclitaxel, Sunitinib, and AKT inhibitor VIII between different risk subgroups. (G, H) Heatmap (G) and volcano plots (H) demonstrate DEGs between two risk subgroups. (I) GO terms of DEGs among different risk subgroups. (J) KEGG enrichment analyses of DEGs among different risk subgroups.